You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adenovirus-vector ChAdOx1 vaccination

Showing 1 - 25 of 4,712
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Herpes Zoster Trial in Halifax (Recombinant Zoster Vaccine (Adenovirus Vector) (ChAdOx1-VZV), Zoster Vaccine Recombinant,

Not yet recruiting
  • Herpes Zoster
  • Recombinant Zoster Vaccine (Adenovirus Vector) (ChAdOx1-VZV)
  • +5 more
  • Halifax, Canada
    Canadian Center for Vaccinology
Aug 6, 2023

Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)

Completed
  • Healthy Adult Volunteers
  • ChAdOx1-nCov-19 (Astra-Zeneca)
  • SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
  • Taipei City, X, Taiwan
    National Taiwan University Hospital
Oct 16, 2022

COVID-19 Trial in Vienna (Ad26COVS1, ChAdOx1 SARS2 Vaccine, BNT162B2)

Active, not recruiting
  • COVID-19
  • Vienna, Austria
    Medicial University of Vienna
Apr 12, 2022

SARS-CoV-2 Vaccine Tolerability and Clinical Outcome Among

Completed
  • SARS-CoV2 Infection
  • +3 more
  • IM injection of vaccination (mRNA vaccination)
  • IM injection of vaccination (vector based vaccination)
  • Hildesheim, Niedersachsen, Germany
    Helios Hospital Hildesheim
Dec 29, 2022

Hepatitis B, Healthy Trial in United Kingdom (ChAdOx1-HBV)

Completed
  • Hepatitis B
  • Healthy
  • ChAdOx1-HBV
  • Southampton, Hampshire, United Kingdom
  • +3 more
Jul 22, 2022

COVID-19 Trial (1 Nebulized inhalation for booster groups, 2 Nebulized inhalation for booster groups, 3 Nebulized inhalation for

Recruiting
  • COVID-19
  • 1 Nebulized inhalation for booster groups
  • +23 more
  • Xiangxi, Hunan, China
    CDC of of Luxi County, Xiangxi Tujia and Miao Autonomous Prefect
Oct 24, 2022

COVID-19 Trial in Al Ain (AZD1222, rAd26-S)

Completed
  • COVID-19
  • AZD1222
  • rAd26-S
  • Al Ain, United Arab Emirates
    Tawam Hospital
Oct 24, 2022

Covid19 Trial in Cypress (VXA-CoV2-1)

Completed
  • Covid19
  • VXA-CoV2-1
  • Cypress, California
    WCCT
Jan 17, 2023

COVID-19 Infection, COVID-19 VACCINE Trial in Thailand (AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) full dose, Pfizer/BioNTech

Completed
  • COVID-19 Infection
  • COVID-19 VACCINE
  • AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) full dose
  • +3 more
  • Bangkok Noi, Bangkok, Thailand
  • +6 more
Jul 3, 2022

COVID-19 Vaccination, Inflammation, Vaccine Immune Response Trial in Suwon, Seoul (either BNT162b2 or ChAdOx1 vaccine)

Recruiting
  • COVID-19 Vaccination
  • +3 more
  • either BNT162b2 or ChAdOx1 vaccine
  • Suwon, Gyeonggi-do, Korea, Republic of
  • +2 more
Apr 6, 2022

Safety, Immunogenicity Trial in Entebbe, Oxford (ChAdOx185A, MVA85A, BCG)

Active, not recruiting
  • Safety
  • Immunogenicity
  • ChAdOx185A
  • +2 more
  • Entebbe, Uganda
  • +1 more
May 13, 2021

COVID-19 Trial in Gaborone (AZD 1222)

Completed
  • COVID-19
  • AZD 1222
  • Gaborone, Botswana
    Botswana Harvard Health Partnership
Feb 6, 2023

HPV Infection, CIN1 Trial in Belgium, Estonia, United Kingdom (ChAdOx1-HPV, MVA-HPV, Placebo)

Active, not recruiting
  • HPV Infection
  • CIN1
  • ChAdOx1-HPV
  • +2 more
  • Antwerp, Belgium
  • +15 more
Jan 9, 2023

Norovirus Infections Trial in Cypress (VXA-G1.1-NN)

Completed
  • Norovirus Infections
  • VXA-G1.1-NN
  • Cypress, California
    WCCT Global, Inc.
Sep 19, 2022

COVID-19, SARS-CoV-2 Acute Respiratory Disease Trial in Spain (COVID-19 Vaccine HIPRA 40 ug/dose, Comirnaty (Pfizer-BioNtech) 30

Recruiting
  • COVID-19
  • SARS-CoV-2 Acute Respiratory Disease
  • COVID-19 Vaccine HIPRA 40 ug/dose
  • Comirnaty (Pfizer-BioNtech) 30 ug/dose concentrate for dispersion for injection
  • Coruña, Spain
  • +6 more
Jul 21, 2022

Adaptive Immune Response to COVID-19 Vaccination

Active, not recruiting
  • SARS-CoV-2 Vaccination
  • Greifswald, MV, Germany
    University Medicine Greifswald
Mar 25, 2022

NSCLC (NSCLC) Trial in United Kingdom (ChAdOx1-MAGEA3-NYESO, MVA-MAGEA3, Standard of care treatment)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • ChAdOx1-MAGEA3-NYESO
  • +2 more
  • Birmingham, United Kingdom
  • +7 more
Dec 16, 2021

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)

Terminated
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • GVAX
  • +6 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2022

Liver Cirrhosis Trial in New Delhi (Covishield)

Recruiting
  • Liver Cirrhosis
  • Covishield
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences
Jun 18, 2021

HIV-1-infection Trial in Kenya, Uganda, Zambia (Vaccine, Placebo)

Active, not recruiting
  • HIV-1-infection
  • Vaccine
  • Placebo
  • Kilifi, Kenya
  • +3 more
Jun 21, 2022

Participants in Preventive HIV Vaccine Studies in Uganda

Completed
  • HIV Infections
    • Kampala, Uganda
      Makerere University Walter Reed Project (MUWRP)
    Oct 28, 2021

    Severe Haemophilia A Trial in United Kingdom (valoctocogene roxaparvovec)

    Active, not recruiting
    • Severe Haemophilia A
    • valoctocogene roxaparvovec
    • Basingstoke, United Kingdom
    • +5 more
    Feb 22, 2022

    COVID-19, SARS-CoV2 Infection Trial in Hamilton (Ad5-triCoV/Mac, ChAd-triCoV/Mac)

    Recruiting
    • COVID-19
    • SARS-CoV2 Infection
    • Ad5-triCoV/Mac
    • ChAd-triCoV/Mac
    • Hamilton, Ontario, Canada
      McMaster University Medical Centre
    Jun 15, 2022

    COVID-19, Breakthrough Infection Trial in Taoyuan city (BNT162b2, mRNA-1273, MVC-COV1901)

    Active, not recruiting
    • COVID-19
    • Breakthrough Infection
    • BNT162b2
    • +2 more
    • Taoyuan city, Taiwan
      Chang Gung Memorial Hospital
    Jul 21, 2022

    SARS-CoV2 Infection Trial in Innsbruck (Vaxzevria, Comirnaty)

    Recruiting
    • SARS-CoV2 Infection
    • Vaxzevria
    • Comirnaty
    • Innsbruck, Tyrol, Austria
      Medical University of Innsbruck
    Sep 9, 2021